Trump Admin Insider Blocks Cannabis Rescheduling Progress
Presidential advisor reveals internal resistance to marijuana rescheduling within Trump administration, creating uncertainty for cannabis reform timeline.
Cannabis reform faces internal roadblocks within the Trump administration as a presidential advisor reveals that someone is actively impeding marijuana rescheduling efforts. The disclosure exposes fractures in the administration's approach to cannabis policy, contradicting previous signals that federal marijuana reform could advance under Trump's second term.
The revelation carries immediate implications for cannabis operators who banked on federal rescheduling to reduce the punitive 280E tax burden that restricts business deductions. Multi-state operators like Curaleaf, Trulieve, and Green Thumb Industries continue operating under the assumption that rescheduling from Schedule I to Schedule III remains viable, but internal administration resistance introduces new timeline uncertainty.
Cannabis stocks rallied following Trump's election victory as investors anticipated a more business-friendly regulatory environment. The sector's performance now hinges on whether pro-reform voices within the administration can overcome internal opposition. Companies with strong state-level market positions may weather federal delays better than those dependent on interstate commerce expansion.
The rescheduling process, initiated under the Biden administration through DEA review, requires final approval that could face indefinite delays if administration officials maintain opposition. This creates a challenging environment for cannabis companies planning 2025 growth strategies around anticipated federal tax relief and banking access improvements.
Investors must now recalibrate expectations for federal cannabis reform timelines. While state-level legalization continues expanding market opportunities, the federal regulatory overhang persists as a constraint on institutional investment and interstate operations. Cannabis companies with efficient operations and strong cash positions will likely outperform during extended federal uncertainty, while highly leveraged operators face continued pressure from restricted access to traditional banking and capital markets.